News & Analysis on Clinical Trial Services & Contract Research And Development
According to a new report, technical advances in the R&D environment have promoted the uptake of biochips in clinical research applications. However, the report identified the high prices as a prime area of concern.
An innovative point-of-care test has proved four times more effective than the conventional laboratory test in detecting the disease, which is encouraging for sufferers of the fifth most common cancer in the US.
In-PharmaTechnologist insulin series
With the first non-injectable insulin to the world market predicted to earn $1.5 bn (€1.2 bn) a year, inhaled pulmonary delivery is winning the race, looking certain to trigger a bitter grapple between the big insulin players.
Global demand for pharmaceutical packaging is tipped to increase 6.3 per cent each year to create a $30 bn (€24.4 bn) market in 2009, pushed by emerging pharma industries, tighter government standards on packaging and the burgeoning advanced drug...
A new report has claimed that the benefits pharma crop producers enjoy have been greatly exaggerated suggesting that any claims regarding high farmer compensation and booming pharma-crop acreage are likely overblown.
Esco Micro is the first company outside of Japan to have a Class II biosafety cabinet certified to the Japanese standard for microbiological testing requirements, which are the most stringent in the world.
Taiwanese generic and contract manufacturer ScinoPharm has seen its sales almost double for the last three years, from $5 m in 2002 to $31m in 2005, fuelled by its booming active pharmaceutical ingredient (API) business.